EP 1165131 A2 20020102 - ATTENUATED DENGUE-1 VIRUS VACCINE
Title (en)
ATTENUATED DENGUE-1 VIRUS VACCINE
Title (de)
ATTENUIERTER DENGUE-1-VIRUS IMPFSTOFF
Title (fr)
VACCIN ANTIVIRAL ATTENUE DU DENGUE DE TYPE 1
Publication
Application
Priority
- US 0008201 W 20000324
- US 12631799 P 19990326
- US 18206400 P 20000211
Abstract (en)
[origin: WO0057908A2] The present invention provides vaccine compositions of attenuated dengue-1 virus. More specifically, the attenuated virus is produced by serial passage in PDK cells. The invention also provides methods for stimulating the immune system of an individual to induce protection against dengue-1 virus by administration of attenuated dengue-1 virus.
IPC 1-7
IPC 8 full level
A61K 39/12 (2006.01); A61K 39/39 (2006.01); A61P 31/12 (2006.01); A61P 31/14 (2006.01); C12N 7/04 (2006.01); C12N 15/09 (2006.01); C12N 15/40 (2006.01); C12Q 1/02 (2006.01)
CPC (source: EP)
A61K 39/12 (2013.01); A61P 31/12 (2017.12); A61P 31/14 (2017.12); A61K 2039/5254 (2013.01); A61K 2039/545 (2013.01); A61K 2039/70 (2013.01); C12N 2770/24134 (2013.01); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 0057908A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0057908 A2 20001005; WO 0057908 A3 20010125; WO 0057908 A9 20011011; AU 4179200 A 20001016; CA 2365728 A1 20001005; EP 1165131 A2 20020102; JP 2002540169 A 20021126
DOCDB simple family (application)
US 0008201 W 20000324; AU 4179200 A 20000324; CA 2365728 A 20000324; EP 00921482 A 20000324; JP 2000607658 A 20000324